Cyteir Therapeutics, Inc.
CYT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$46,061 | -$42,126 | -$20,823 | -$15,044 |
| Dep. & Amort. | $668 | $479 | $351 | $215 |
| Deferred Tax | $0 | -$4,423 | -$142 | $0 |
| Stock-Based Comp. | $4,682 | $3,465 | $467 | $247 |
| Change in WC | -$2,528 | $2,150 | $1,466 | -$2,160 |
| Other Non-Cash | $707 | $4,423 | $142 | -$815 |
| Operating Cash Flow | -$42,532 | -$36,032 | -$18,539 | -$17,557 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$312 | -$1,189 | -$850 | -$133 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$312 | -$1,189 | -$850 | -$133 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $64 | $0 | $1,427 | $36,890 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $242 | $216,006 | $1,427 | $36,890 |
| Financing Cash Flow | $242 | $216 | $1,427 | $36,890 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$42,602 | $178,785 | -$17,962 | $19,200 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $189,979 | $11,194 | $29,156 | $9,956 |
| End Cash | $147,377 | $189,979 | $11,194 | $29,156 |
| Free Cash Flow | -$42,844 | -$37,221 | -$19,389 | -$17,690 |